Joel Greenblatt’s PDS Biotechnology PDSB Stock Holding History

Joel Greenblatt’s Portfolio PDSB Stock Details PDSB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-15,429	Closed	-$219K	–	1062
2020 Q4	$219K	Buy	+15,429	New	+$33.8K	0.01%	913

Other funds holding PDSB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

IWA

Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

MWM

Minot Wealth Management Westwood, Massachusetts $389M AUM 3.39% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Joel Greenblatt's PDSB Position: Q1 2021 in Review

Joel Greenblatt sold out of PDS Biotechnology (PDSB) in Q1 2021, closing a stake of 15,429 shares — an estimated $219K sold.

Joel Greenblatt first reported a position in PDSB in Q4 2020 and held it in 1 quarter. The position peaked at $219K in Q4 2020. 32 funds tracked by Wall St. Rank hold PDSB as of Q1 2021.

Joel Greenblatt reported no remaining PDS Biotechnology position as of Q1 2021 after selling out during the quarter.
Joel Greenblatt sold 15,429 PDS Biotechnology shares in Q1 2021, an estimated $219K.
Joel Greenblatt first reported a position in PDS Biotechnology in Q4 2020 and held it in 1 quarter.
Joel Greenblatt's PDS Biotechnology position peaked at $219K in Q4 2020.
32 funds tracked by Wall St. Rank held PDS Biotechnology as of Q1 2021.

Based on Gotham Asset Management's 13F filing for Q1 2021, filed 17 May 2021.